Baylor Research Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Baylor Research Institute sits in the top decile of US sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count).

180 total trials 31 currently recruiting 103 completed early-phase tilt top decile by trial count

Baylor Research Institute: 180 sponsored US clinical trials, 31 recruiting.

Baylor Research Institute sponsors 180 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 13 of these trials are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 5 trials.

Top-decile sponsor footprint

Baylor Research Institute ranks in the top decile of sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 45/100

103 of 125 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

180 total, page 3 of 4

TERMINATED

Prognosis and Therapeutic Biomarkers for Glioblastoma Patients

NCT03403803

COMPLETED NA

Harmonica Playing Improves Quality of Life in Patients With COPD

NCT03442140

TERMINATED NA

Resting Metabolic Rate Testing in Bariatric Surgery Patients

NCT03221543

COMPLETED

Early Onset Alzheimer's Disease Genomic Study

NCT03645993

COMPLETED NA

Workout on Wheels Internet Intervention (WOWii)

NCT03189095

TERMINATED NA

Living Organ Donor Recovery Enhancement Program

NCT03865264

COMPLETED

Bioelectrical Impedance Spectroscopy in Heart Transplantation: Tracking Post-Transplant Changes in Body Composition and Correlation With Conventional Preoperative Risk Assessment Modalities

NCT03373279

COMPLETED NA

Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification (SITRAL) Study

NCT02830204

COMPLETED

Vascular Post Market Review

NCT02681341

COMPLETED Early Phase 1

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

NCT02550327

COMPLETED Phase 3

Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome

NCT02251431

COMPLETED

Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

NCT02827448

TERMINATED

Functional Assessment in Liver Transplantation

NCT03870568

TERMINATED Phase 1

Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer

NCT02548169

COMPLETED

Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation

NCT02412579

COMPLETED NA

Left Atrial Appendage Closure With SentreHeart Lariat® Device

NCT02681042

COMPLETED

Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE)

NCT02332070

COMPLETED

Pacemaker Utilization and Ventricular Pacing in Patients Undergoing Trans-catheter Aortic Valve Replacement (TAVR)

NCT02994667

COMPLETED

Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations

NCT02477930

COMPLETED NA

Self Directed Stations for the Stroke Patient

NCT02446197

TERMINATED NA

Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders

NCT02482337

COMPLETED Phase 1

Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer

NCT02018458

COMPLETED Phase 4

Trial Comparing Angiography and Angiography With IVUS for Treatment of Hemodialysis Access Failures

NCT02056704

COMPLETED

Low-dose-contrast Cardiac Computed Tomography

NCT02146768

COMPLETED

Paravalvular Leak for Transcatheter Valve Replacement

NCT02079129

TERMINATED

Gastroesophageal Reflux Disease Prospective Registry

NCT02479438

COMPLETED Phase 1

A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy

NCT02021422

COMPLETED

Non-contrast 3-dimensional Cardiac Magnetic Resonance Imaging

NCT04496297

COMPLETED NA

Comparing FEES to VFSS in Diagnosing Laryngeal Penetration and Aspiration in Infants in the NICU

NCT02003287

TERMINATED NA

Evaluation of the Endometrial Cavity After Endometrial Ablation

NCT02087228

COMPLETED

Improving Echo Measurements in the Diagnosis of Aortic Stenosis

NCT02146755

COMPLETED

Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors

NCT01922323

COMPLETED NA

Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage

NCT02229513

COMPLETED

Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery

NCT01890460

COMPLETED

Immune Signature of Palmoplantar Pustulosis

NCT01780857

COMPLETED

Prospective Balloon Aortic Valvuloplasty

NCT02122900

COMPLETED

Imaging Dopamine Function and Its Impact on Outcome After Traumatic Brain Injury (TBI)

NCT01850290

COMPLETED NA

Better Me Within Trial to Improve Lifestyle Behaviors in African Americans

NCT04082702

COMPLETED Phase 1

Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients

NCT01802970

COMPLETED

Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

NCT02070315

COMPLETED NA

Laser Atherectomy Versus Angioplasty for the Treatment of Critical Limb Ischemia

NCT01579123

COMPLETED NA

Analgesic Efficacy of a Multiport Versus Uniport Flexible Catheter for Labor Epidural Analgesia

NCT01861821

TERMINATED Phase 2

Quantitative Liver Function Tests Using Cholates

NCT01907074

TERMINATED

Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey

NCT01378351

COMPLETED

Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

NCT03136679

COMPLETED NA

Determinants of Fat Malabsorption After Roux-en-Y Gastric Bypass

NCT01252511

COMPLETED Phase 1

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

NCT01189383

COMPLETED

Assessment of Renal Function in Cirrhotic Patients

NCT01895114

COMPLETED

Androgenetic Alopecia in Fabry Disease

NCT01295008

COMPLETED

Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique

NCT01540422

← Previous Page 3 of 4 Next →

Phase Distribution

PhaseTrial count
Phase 1 19
Phase 2 14
Phase 3 2
Phase 4 11

What is open in the Baylor Research Institute pipeline

31 recruiting of 180 indexed (17% open); 103 completed (57%).

Phase mix: 13 late (III/IV) vs 33 early (I/II) (early-phase heavy).

Top condition: Stroke (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Baylor Research Institute: open-pipeline peers nationwide

Peers matched on 180 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20% Total trials Recruiting share Baylor Research InstituteAbbottViiV HealthcareUConn HealthFox Chase Cancer CenterEmory UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Hunter College of City University of New YorkOchsner Health System
Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 180 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Baylor Research Institute page

180 registered trials is a research-attention snapshot, not an endorsement of Baylor Research Institute or any single study.

  • 31 of Baylor Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Baylor Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor Research Institute pipeline card: 180 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.